Bowman-Birk inhibitor product for use as an anticarcinogenesis agent
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 16, 1994
Issued Date -
N/A
app pub date -
Nov 2, 1992
filing date -
Sep 6, 1990
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Methods for the suppression and inhibition of carcinogenesis are provided in which a Bowman-Birk product produced in accordance with the processes described are administered. The methods are particularly adaptable to the prevention or treatment of colon, lung, liver, esophagus, oral epithelium (squamous carcinomas), and bone marrow cancer. The preferred mode of administration is as a dietary supplement.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully